Clinical Trials Browser

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT05361668 2026-03-19

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Phase 2 Completed

36 enrolled 19 charts

EndocrineNET

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT04713202 2023-02-10

NET-PACS

Phase 2 Withdrawn

EndocrineNET

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

NCT03722511 2022-11-03

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

Phase 2 Completed

10 enrolled

EndocrineNET

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

NCT00774930 2022-10-14

ELECT

Phase 3 Completed

115 enrolled 17 charts

EndocrineNET

Carcinoid Tumor, Diarrhea, Flushing, Neuroendocrine Tumors, Serotonin Syndrome

NCT04073017 2021-05-21

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

Phase NA Terminated

11 enrolled

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

NCT04140409 2019-10-25

SCIROCCO

Phase 4 Terminated

10 enrolled

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

NCT02299089 2017-12-15

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Phase 2 Completed

12 enrolled 18 charts

EndocrineNET

Acromegaly, Neuroendocrine Tumors, Serotonin Syndrome

Clinical Trials

CAREFNDR

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

NET-PACS

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

ELECT

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

SCIROCCO

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)